SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the Association of Sarcoidosis Granulomatous and other Disorders (WASOG) adopted by the ERS Executive Committee, February, 1999. Am J Resp Crit Care Med 1999; 160: 73655.
  • 2
    Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001; 32: 5668.
  • 3
    Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. Am Rev Respir Dis 1984; 130: 2932.
  • 4
    Nowinski TS. Ocular manifestations of sarcoidosis. Curr Opin Ophthalmol 1998; 9: 804.
  • 5
    Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996; 103: 184653.
  • 6
    Usui Y, Kaiser E, See RF, Rao NA, Sharma OP. Update of ocular manifestations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 16775.
  • 7
    Smith JA, Foster CS. Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin 1996; 36: 10925.
  • 8
    Lardenoye CW, van der Lelij A, de Loos WS, Treffers WF, Rothova A. Peripheral multifocal chorioretinitis: a distinct clinical entity? Ophthalmology 1997; 104: 18206.
  • 9
    Kaiser PK, Lowder CY, Sullivan P, Sanislo SR, Kosmorsky GS, Meziane MA, et al. Chest computed tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 2002; 133: 499505.
  • 10
    Holladay JT. Proper method for calculating average visual acuity. J Refract Surg 1997; 13: 38891.
  • 11
    Kraut JA, McCabe CP. The problem of low vision: definition and common problems. In: Albert DM, Jakobiec FA, editors. Principles and practice of ophthalmology. Philadelphia: WB Saunders; 1994. p. 36646.
  • 12
    Nishimura K, Itoh H, Kitaichi M, Nagai S, Izumi T. Pulmonary sarcoidosis: correlation of CT and histopathologic findings. Radiology 1993; 189: 1059.
  • 13
    The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990; 141: S169202.
  • 14
    Kantrow SP, Meyer KC, Kidd P, Raghu G. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997; 10: 271621.
  • 15
    Holmquist B, Bunning P, Riordan JF. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 1979; 95: 5408.
  • 16
    Deutsch TA, Tessler HH. Inflammatory pseudohistoplasmosis. Ann Ophthalmol 1985; 17: 4615.
  • 17
    Vrabec TR, Augsburger JJ, Fischer DH, Belmont JB, Tashayyod D, Israel HL. Taches de bougie. Ophthalmology 1995; 102: 171221.
  • 18
    Brod RD. Presumed sarcoid choroidopathy mimicking Birdshot retinopathy. Am J Ophthalmol 1990; 109: 3578.
  • 19
    Perez Alvarez MJ, Gonzales Guijarro J, Santos Gil I. Tuberculoous peripheral multifocal choroiditis. Arch Soc Esp Oftalmol 2003; 78: 16972.
  • 20
    Hershey JM, Pulido JS, Folberg R, Folk JC, Massicotte SJ. Non-caseating conjunctival granulomas in patients with multifocal choroiditis and panuveitis. Ophthalmology 1991; 101: 596601.
  • 21
    Studdy P, James D, Bird R, and coauthors. Serum angiotensin-converting enzyme: experience in 10 centers. In Williams WJ, Davies BH, editors. Proceedings of the 8th International Conference on Sarcoidosis and Other Granulomatous Diseases, 1978. Cardiff: Alpha Omega Publishing; 1980. p. 2415.
  • 22
    Takahashi T, Azuma A, Abe S, Kawanami O, Ohara K, Kudoh S. Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis. Eur Respir J 2001; 18: 51521.
  • 23
    Keogh BA, Hunninghake GW, Line BR, Crystal RG. The alveolitis of pulmonary sarcoidosis: evaluation of natural history and alveolitis dependent changes in lung function. Am Rev Respir Dis 1983; 28: 25665.
  • 24
    Rossman MD, Dauber JH, Daniele RP. Identification of activated T cells in sarcoidosis. Am Rev Respir Dis 1978; 117: 71320.
  • 25
    Karma A, Poukkula AA, Ruokonen AO. Assessment of activity of ocular sarcoidosis by gallium scanning. Br J Ophthalmol 1987; 71: 3617.
  • 26
    Power WJ, Neves RA, Rodriguez A, Pedroza-Seres M, Foster CS. The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology 1995; 102: 200711.
  • 27
    Sulavik SB, Palestro CJ, Spencer RP, Swyer AJ, Goldsmith SJ, Tierstein AS. Extrapulmonary sites of radiogallium accumulation in sarcoidosis. Clin Nucl Med 1990; 15: 8768.
  • 28
    Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990; 31: 190914.
  • 29
    Callanan P, Jost BF. New findings in ocular histoplasmosis. Curr Opin Ophthalmol 1995; 6: 812.
  • 30
    Rodenker HT, Ganley HP. Ocular coccidioidomycosis. Surv Ophthalmol 1980; 24: 26390.
  • 31
    Lim JI, Tessler HH, Goodwin JA. Anterior granulomatous uveitis in patients with multiple sclerosis. Ophthalmology 1991; 98: 1425.
  • 32
    Dev S, McCallum RM, Jaffe GJ. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 1999; 106: 1118.
  • 33
    Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 606.